Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment Patterns and Decision Drivers in Chinese Patients with Locally Advanced Cervical Cancer: Results from a National Physician Survey.

Advances in therapy·2026
Same author

Spatiotemporal mapping of CD112 unveils its dichotomous role in T-cell exhaustion and ferroptosis crosstalk in cervical cancer.

Cell death & disease·2026
Same author

NSUN4 Suppresses Ferroptosis Through m<sup>5</sup>C-Dependent Stabilization of C-MYC and Activation of the PI3K/Akt Signaling Pathway in Cervical Cancer.

Cancers·2026
Same author

Rare Case of Parametrial Molar Pregnancy With Typical Imaging of Ultrasound and Magnetic Resonance Imaging: A Case Report.

Journal of clinical ultrasound : JCU·2026
Same author

Oncology and Fertility Outcomes for Patients with Stage IC Adult Granulosa Cell Tumor of the Ovary.

Annals of surgical oncology·2026
Same author

ASO Author Reflections: Balancing Fertility Preservation and Oncologic Safety in Stage IC Adult Granulosa Cell Tumors.

Annals of surgical oncology·2026
Same journal

Development and Validation of Salivary Exosomal Tri-RNA Liquid Biopsy in Esophageal Carcinoma: A Multicenter Study.

JCO precision oncology·2026
Same journal

Implementing Timely Germline Genetic Testing for Patients With Pancreatic Cancer Using a Genetics Copilot for Point-of-Care Education and Health Assessment.

JCO precision oncology·2026
Same journal

Integrating DNA Mutations and RNA Expression of Cancer Driver Genes in Asian Rare Cancers: A Pan-Cancer Analysis.

JCO precision oncology·2026
Same journal

Sustained Response to Trametinib in Central Giant Cell Granuloma With <i>KRAS</i> Gain-of-Function Mutation: A Case Report.

JCO precision oncology·2026
Same journal

DNA Damage Response Alterations and Immune Checkpoint Blockade Outcomes Across Multiple Cancers.

JCO precision oncology·2026
Same journal

Prediction of Anthracycline Benefit in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Early-Stage Breast Cancer by the MammaPrint 70-Gene Signature for Patients Enrolled in the FLEX Study.

JCO precision oncology·2026
See all related articles

Related Experiment Video

Updated: Jun 26, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

Development of a Machine Learning‑Based Prognostic Model for Intermediate Trophoblastic Tumors: A Single-Center Study

Weidi Wang1, Yunshu Jiao2, Yuan Li1

  • 1National Clinical Research Center for Women's Health and Obstetric and Gynecologic Diseases, Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

JCO Precision Oncology
|June 12, 2026
PubMed
Summary
This summary is machine-generated.

This study developed a machine learning model to predict progression-free survival for intermediate trophoblastic tumors (ITT). The model integrates immune markers and clinicopathologic features, offering improved risk stratification for patients with this rare malignancy.

More Related Videos

Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis
12:41

Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis

Published on: December 23, 2022

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

Related Experiment Videos

Last Updated: Jun 26, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis
12:41

Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis

Published on: December 23, 2022

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

Area of Science:

  • Gynecologic Oncology
  • Machine Learning in Medicine
  • Cancer Prognostics

Background:

  • Current prognostic systems for intermediate trophoblastic tumors (ITT) are insufficient.
  • Accurate risk stratification is crucial for personalized treatment of ITT.

Purpose of the Study:

  • To develop a machine learning (ML)-based prognostic model for predicting progression-free survival (PFS) in patients with ITT.
  • To create a web-based tool for individualized risk stratification of ITT.

Main Methods:

  • Retrospective analysis of 236 ITT patients (2000-2024).
  • Multimodal feature selection integrating Cox regression, LASSO, GBM, and RSF.
  • Prognostic model built using Random Survival Forest (RSF) with nested 5-fold cross-validation.

Main Results:

  • Identified five key predictors: FIGO stage, interval from antecedent pregnancy, Ki-67 index, neutrophil-to-lymphocyte ratio, and systemic immune-inflammation index.
  • RSF model showed strong discrimination (C-index 0.816) and calibration (IBS 0.113).
  • An interactive web tool was developed for real-time PFS prediction.

Conclusions:

  • Presents the first ML-based prognostic model specifically for ITT.
  • The RSF model, incorporating immune-inflammatory markers, outperforms traditional staging.
  • The online tool facilitates personalized decision-making and future external validation.